QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-stoke-therapeutics-maintains-22-price-target

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $22 price target.

 cantor-fitzgerald-reiterates-overweight-on-stoke-therapeutics

Cantor Fitzgerald analyst Charles Duncan reiterates Stoke Therapeutics (NASDAQ:STOK) with a Overweight.

 whats-going-on-with-stoke-therapeutics-stock-tuesday

After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of...

 crude-oil-moves-lower-td-synnex-earnings-top-estimates

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 dow-gains-100-points-mccormick-posts-upbeat-results

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0...

 nasdaq-gains-over-50-points-us-durable-goods-orders-rise-in-february

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% t...

 wedbush-maintains-outperform-on-stoke-therapeutics-raises-price-target-to-17

Wedbush analyst Laura Chico maintains Stoke Therapeutics (NASDAQ:STOK) with a Outperform and raises the price target from $1...

 stoke-therapeutics-anti-epilepsy-drug-candidate-shows-substantial-sustained-reductions-in-seizure-frequency-in-pretreated-patients

New data from Stoke Therapeutics' STK-001 studies reveal significant reductions in seizures and cognitive improvements in c...

 tesla-to-120-here-are-10-top-analyst-forecasts-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Core News & Articles
Market-Moving News for March 26th
03/26/2024 12:26:11

STOK: 101% | Stoke Therapeutics shares are trading higher after the company announced Phase 1/2a data supporting the potential ...

 why-stoke-therapeutics-shares-are-trading-higher-by-around-70-here-are-20-stocks-moving-premarket

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION